Integrated Oncology

For Patients

MyTestingOptions.com

Prepare for visits with your doctor or a genetic counselor by learning about testing.

MyTestingOptions.com

Working with Integrated Oncology

 

Integrated Oncology Highlights

ProsignaTM Breast Cancer Prognostic Gene Signature Assay, which is based on the PAM50 gene signature, is an FDA 510(k) cleared assay to assess a patient’s risk of distant recurrence of disease.   Learn more...

IntelliGENSM Oncology Therapeutic Panel (NGS) assay assay provides an assessment of targetable mutations within a panel of cancer genes known to be involved in the development, progression and/or treatment of cancers.  Learn more…

Now available!  BRCAssureSM BRCA 1 and 2 Analysis. Learn more about BRCAssureSM.  Learn more about Hereditary Breast and Ovarian Cancer.

HistoPlusSM: Lung Cancer Gene Expression Assay in Non-Small Cell Lung Cancer. A quantitative real-time PCR assay that can be used to distinguish adenocarcinoma from squamous cell cancer subtypes.  Learn more…

Detect ROS1 and RET Gene Rearrangements in Non-Small Cell Lung Cancer
ROS1 and RET gene rearrangements define distinct subpopulations of NSCLC patients who may derive benefit from targeted therapies. Learn more…